📰 Ntla 2001 News
Ntla 2001 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ntla 2001. Real-time updates on events, politics, business and more.
February 6, 2024
Armed with strong phase III safety data in Japanese patients, Palo Alto, Calif.-based Bridgebio Pharma Inc. is planning to file for Japan approval of its investigational drug acoramidis for a rare heart disorder.
October 18, 2023
Intellia Therapeutics, Inc. (NTLA) announced the FDA has cleared the company's Investigational New Drug application for NTLA-2001 for the treatment of transthyretin amyloidosis with cardiomyopathy.